Research Article
Meta-Analysis of Microarray Data Identifies GAS6 Expression as an Independent Predictor of Poor Survival in Ovarian Cancer
Table 1
Clinicopathological data for nonmucinous EOC cohort (
).
| Variable | Number | % |
| Age at diagnosis | | | >60 | 97 | 56.4 | <60 | 73 | 43.6 | FIGO stage | | | I | 32 | 18.6 | II | 17 | 9.9 | III | 72 | 41.9 | IV | 43 | 25.0 | NA | 8 | 4.6 | TNM-T | | | 1 | 32 | 18.6 | 2 | 21 | 12.2 | 3 | 107 | 62.2 | 4 | 7 | 4.1 | NA | 5 | 2.9 | TNM-N | | | 0 | 96 | 55.8 | 1 | 41 | 23.8 | NA | 35 | 20.4 | TNM-M | | | 0 | 101 | 58.7 | 1 | 45 | 26.2 | NA | 26 | 15.1 | Grade | | | 1 | 15 | 8.7 | 2 | 58 | 33.7 | 3 | 98 | 57.0 | NA | 1 | 0.6 | Histological type | | | Serous (SOC) | 84 | 48.8 | Endometrioid (EnOC) | 39 | 22.7 | Clear cell (ClCOC) | 42 | 24.4 | Transitional cell (TCOC) | 7 | 4.1 | Ascites at primary diagnosis | | | Yes | 89 | 51.7 | No | 83 | 48.3 | Residual disease | | | ≥10 mm | 84 | 48.8 | ≤10 mm | 49 | 28.5 | NA | 32 | 22.7 | Primary cancer origin | | | Both ovaries | 80 | 46.5 | Left ovary | 43 | 25.0 | Right ovary | 40 | 23.2 | NA | 9 | 5.3 | Performance status | | | Healthy | 77 | 44.8 | Systematic disease | 55 | 31.9 | Severely sick | 1 | 0.6 | NA | 39 | 22.7 | With cancer family history CA125 (preoperative) | | | Yes | 40 | 23.3 | ≥35 U/mL | 75 | 43.6 | ≤35 U/mL | 10 | 5.8 | NA | 87 | 50.6 | Relapse | | | Yes | 140 | 81.4 | No | 32 | 18.6 | Platinum chemotherapy | | | Sensitive | 45 | 26.2 | Resistant | 93 | 54.0 | NA | 34 | 19.8 | Outcome | | | Death related to malignancy | 88 | 51.2 | Unrelated, no disease | 1 | 0.6 | NA | 83 | 48.2 | Progressive disease (months) | | | Yes | 36 | 20.9 | No | 136 | 79.1 |
|
|